{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:23:25Z","timestamp":1761593005238,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ncl.2025.05.008","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:45:35Z","timestamp":1757015135000},"page":"711-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cryptogenic Sensory Polyneuropathy and Metabolic Syndrome"],"prefix":"10.1016","volume":"43","author":[{"given":"Mamatha","family":"Pasnoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2025.05.008_bib1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bmj.324.7335.466","article-title":"Peripheral neuropathy","volume":"324","author":"Hughes","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ncl.2025.05.008_bib2","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.0000000000003293","article-title":"Prevalence of polyneuropathy in the general middle-aged and elderly population","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.24969","article-title":"Causes of neuropathy in patients referred as \"idiopathic neuropathy\"","volume":"53","author":"Farhad","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.008_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jdi.12650","article-title":"Peripheral neuropathy in prediabetes and the metabolic syndrome","volume":"8","author":"Stino","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.ncl.2025.05.008_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ncl.2013.01.008","article-title":"Cryptogenic sensory polyneuropathy","volume":"31","author":"Pasnoor","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2025.05.008_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.56.5.540","article-title":"Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics","volume":"56","author":"Wolfe","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mus.27070","article-title":"Diagnostic criteria for idiopathic small fiber neuropathy: a systematic review","volume":"63","author":"Haroutounian","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.008_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.0000000000010988","article-title":"Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria","volume":"95","author":"Freeman","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0404.1983.tb04560.x","article-title":"Chronic cryptogenic polyneuropathy the search for a cause","volume":"67","author":"Fagius","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2025.05.008_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/00207454.2013.782026","article-title":"North America and South America (NA-SA) neuropathy project","volume":"123","author":"Pasnoor","year":"2013","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.ncl.2025.05.008_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","article-title":"The epidemiology and risk factors of chronic polyneuropathy","volume":"31","author":"Hanewinckel","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ncl.2025.05.008_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.mayocp.2015.05.004","article-title":"Peripheral neuropathy: a practical approach to diagnosis and symptom management","volume":"90","author":"Watson","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2025.05.008_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ncl.2013.02.001","article-title":"Pattern-recognition approach to neuropathy and neuronopathy","volume":"31","author":"Barohn","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2025.05.008_bib14","first-page":"732","article-title":"Peripheral neuropathy: evaluation and differential diagnosis","volume":"102","author":"Castelli","year":"2020","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ncl.2025.05.008_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib16","first-page":"14","volume":"1","author":"England","year":"2009","journal-title":"Pharm Manag PM R"},{"key":"10.1016\/j.ncl.2025.05.008_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamaneurol.2019.2917","article-title":"Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review","volume":"76","author":"Oaklander","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1085-9489.2005.10106.x","article-title":"Cryptogenic polyneuropathy: clinical and neurophysiological findings","volume":"10","author":"Lindh","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ncl.2025.05.008_bib19","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/mus.1132","article-title":"Prospective follow-up study of chronic polyneuropathy of undetermined cause","volume":"24","author":"Jann","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.008_bib20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.2006.091074","article-title":"Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy","volume":"77","author":"De Sousa","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2025.05.008_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0404.1995.tb00150.x","article-title":"Idiopathic distal small fiber neuropathy","volume":"92","author":"Gorson","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2025.05.008_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awh192","article-title":"A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy","volume":"127","author":"Hughes","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2025.05.008_bib23","doi-asserted-by":"crossref","first-page":"e2236","DOI":"10.1212\/WNL.0000000000012894","article-title":"Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability","volume":"97","author":"Johnson","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archneur.59.4.533","article-title":"Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people","volume":"59","author":"Vrancken","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-444-53480-4.00009-6","article-title":"Glucose intolerance, metabolic syndrome, and neuropathy","volume":"126","author":"Cortez","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mus.27086","article-title":"Metabolic syndrome and peripheral neuropathy","volume":"63","author":"Kazamel","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.008_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.24310","article-title":"Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients","volume":"77","author":"Singleton","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.2830340204","article-title":"Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations","volume":"34","author":"Allen","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ncl.2025.05.008_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(94)90149-X","article-title":"Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies","volume":"96","author":"Savage","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ncl.2025.05.008_bib31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.1984.03340380031018","article-title":"Benign' monoclonal gammopathy. A misnomer?","volume":"251","author":"Kyle","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2025.05.008_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0025-7125(16)30276-0","article-title":"Peripheral neuropathies associated with monoclonal proteins","volume":"77","author":"Bosch","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ncl.2025.05.008_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(95)00021-6","article-title":"Neuropathies associated with monoclonal gammopathies","volume":"6","author":"Kissel","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2025.05.008_bib34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199805283382207","article-title":"Neuropathies associated with paraproteinemia","volume":"338","author":"Ropper","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2025.05.008_bib35","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.410370705","article-title":"Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies","volume":"37","author":"Latov","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","article-title":"Monoclonal gammopathy-associated peripheral neuropathy: diagnosis and management","volume":"92","author":"Chaudhry","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2025.05.008_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.41.3.357","article-title":"Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein","volume":"41","author":"Pestronk","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-5728(93)90077-C","article-title":"Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy","volume":"43","author":"Nemni","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ncl.2025.05.008_bib39","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.57.12.1525","article-title":"Chronic idiopathic axonal polyneuropathy: a five year follow up","volume":"57","author":"Notermans","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2025.05.008_bib40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"61","author":"Sandroni","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2012-302833","article-title":"The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features","volume":"84","author":"Koike","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2025.05.008_bib43","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","article-title":"Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies","volume":"90","author":"Burnor","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib44","first-page":"495","article-title":"Autosomal dominant Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies: detection of the recombination in Slovene patients and exclusion of the potentially recessive Thr118Met PMP22 point mutation","volume":"1","author":"Leonardis","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ncl.2025.05.008_bib45","first-page":"853","article-title":"Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication","volume":"53","author":"Wise","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2025.05.008_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/humu.9261","article-title":"Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients","volume":"24","author":"Choi","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ncl.2025.05.008_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000472166","article-title":"Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study","volume":"4","author":"Nelis","year":"1996","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ncl.2025.05.008_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of function Nanu1.7 mutations in idiopathic small fiber neuropathy","volume":"71","author":"Faber","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mus.27368","article-title":"Diagnostic yield of advanced genetic testing in patients with hereditary neuropathies: a retrospective single-site study","volume":"64","author":"Felice","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.008_bib50","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jnnp.56.10.1066","article-title":"Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients","volume":"56","author":"Notermans","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2025.05.008_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.410440111","article-title":"Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases","volume":"44","author":"Holland","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib52","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/WNL.53.8.1641","article-title":"Painful sensory neuropathy: prospective evaluation using skin biopsy","volume":"53","author":"Periquet","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/brain\/awg007","article-title":"Sensory function in spinal cord injury patients with and without central pain","volume":"126","author":"Finnerup","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2025.05.008_bib54","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.60.3.465","article-title":"Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy","volume":"60","author":"Freeman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.pain.2010.11.013","article-title":"Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study","volume":"152","author":"Geber","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ncl.2025.05.008_bib56","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/01.WNL.0000058546.16985.11","article-title":"Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"60","author":"Shy","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1085-9489.2004.09302.x","article-title":"Sensory CIDP presenting as cryptogenic sensory polyneuropathy","volume":"9","author":"Chin","year":"2004","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ncl.2025.05.008_bib58","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archneur.55.12.1513","article-title":"Epidermal nerve fiber density: normative reference range and diagnostic efficiency","volume":"55","author":"McArthur","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib59","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"Devigili","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2025.05.008_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2007.01.052","article-title":"Concordance between epidermal nerve fiber density and sensory examination in patients with symptoms of idiopathic small fiber neuropathy","volume":"255","author":"Walk","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ncl.2025.05.008_bib61","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.53.8.1634","article-title":"Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies","volume":"53","author":"Herrmann","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib62","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","article-title":"EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy","volume":"12","author":"Lauria","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib63","first-page":"217","article-title":"Clinical electrophysiologic and skin biopsyfindings in cryptogenic sensorimotor polyneuropathy compared to diabetic polyneuropathy and normal controls","volume":"72","author":"Pasnoor","year":"2009","journal-title":"Neurology"},{"issue":"7_supplement_1","key":"10.1016\/j.ncl.2025.05.008_bib64","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000206420","article-title":"Ratio of distal to proximal epidermal nerve fiber density in small fiber neuropathy (P1-11.006)","volume":"102","author":"Dib","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.008_bib65","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.410100304","article-title":"Intensive evaluation of referred unclassified neuropathies yields improved diagnosis","volume":"10","author":"Dyck","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.1991.tb04942.x","article-title":"Cryptogenetic polyneuropathies: an out-patient follow-up study","volume":"84","author":"Grahmann","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2025.05.008_bib67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.47.5.530","article-title":"Chronic polyneuropathy of undetermined cause","volume":"47","author":"McLeod","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 6","key":"10.1016\/j.ncl.2025.05.008_bib68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/brain\/120.6.955","article-title":"Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy. A clinical and electrophysiological study","volume":"120","author":"Teunissen","year":"1997","journal-title":"Brain"},{"issue":"Pt 2","key":"10.1016\/j.ncl.2025.05.008_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/brain\/119.2.421","article-title":"Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy","volume":"119","author":"Notermans","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2025.05.008_bib70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/00207454.2011.582238","article-title":"Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy","volume":"121","author":"Mittal","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.ncl.2025.05.008_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamaneurol.2020.2590","article-title":"Patient assisted intervention for neuropathy: comparison of treatment in real life situations (PAIN-CONTRoLS): Bayesian adaptive comparative effectiveness randomized trial","volume":"78","author":"Barohn","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib72","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ncl.2025.05.008_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.ncl.2025.05.008_bib75","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ncl.2025.05.008_bib76","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ncl.2025.05.008_bib77","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2023.3711","article-title":"Safety and efficacy of topiramate in individuals with cryptogenic sensory peripheral neuropathy with metabolic syndrome: the TopCSPN randomized clinical trial","volume":"80","author":"Smith","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2025.05.008_bib78","first-page":"345","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American association of neuromuscular and electrodiagnostic medicine, and the American Academy of physical medicine and rehabilitation","volume":"3","author":"Bril","year":"2011","journal-title":"Pharm Manag PM R"},{"key":"10.1016\/j.ncl.2025.05.008_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jca.21944","article-title":"Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: a case series of 17 patients","volume":"37","author":"Olsen","year":"2022","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ncl.2025.05.008_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.27745","article-title":"A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies","volume":"67","author":"Gibbons","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.008_bib81","doi-asserted-by":"crossref","DOI":"10.1177\/21501319241309168","article-title":"Metabolic syndrome: an updated review on diagnosis and treatment for primary care clinicians","volume":"15","author":"Peterseim","year":"2024","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.ncl.2025.05.008_bib82","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1046\/j.1532-5415.2002.50503.x","article-title":"Factors associated with falls in older patients with diffuse polyneuropathy","volume":"50","author":"Richardson","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ncl.2025.05.008_bib83","doi-asserted-by":"crossref","first-page":"E416","DOI":"10.1188\/12.ONF.E416-E424","article-title":"Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research","volume":"39","author":"Tofthagen","year":"2012","journal-title":"Oncol Nurs Forum"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:19:36Z","timestamp":1761592776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861925000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0733861925000271"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.008","relation":{},"ISSN":["0733-8619"],"issn-type":[{"type":"print","value":"0733-8619"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptogenic Sensory Polyneuropathy and Metabolic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}